Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Grasemann, Hartmut ^a,b   Schwiertz, Raphael ^a   Grasemann, Corrina ^a   Vester, Udo ^a   Racké, Kurt ^c   Ratjen, Felix ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; ARGINASE; ARGININE; BUDESONIDE; CEFTAZIDIME; GLUTAMIC ACID; MEROPENEM; ORNITHINE; PROLINE; STEROID;

ADULT; AMINO ACID BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 33745739549     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-87     Document Type: Article

References (43)

1. Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G: Nitric oxide in and disease of the respiratory system. Physiol Rev 2004, 84:731-765.
2. Grasemann H, Michler E, Wallot M, Ratjen F: Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997, 24:173-177.
3. Grasemann H, Gaston B, Fang K, Paul K, Ratjen F: Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function. J Pediatr 1999, 135:770-772.
4. Elphick HE, Demoncheaux EA, Ritson S, Higenbottam TW, Everard ML: Exhaled nitric oxide is reduced in infants with cystic fibrosis. Thorax 2001, 56:151-152.
5. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, Gruenert DC, Gyi KM, Hodson ME, Yacoub MH, Polak JM: Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998, 184:323-331.
6. Mhanna MJ, Ferkol T, Martin RJ, Dreshaj IA, van Heeckeren AM, Kelley TJ, Haxhiu MA: Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am J Respir Cell Mol Biol 2001, 24:621-626.
7. Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F: Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000, 162:2172-2176.
8. Texereau J, Marullo S, Hubert D, Coste J, Dusser DJ, Dall'Ava-Santucci J, Dinh-Xuan AT: Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis. Thorax 2004, 59:156-158.
9. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F: Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 2005, 172:1523-1528.
10. Hey C, Boucher JL, Vadon-Le Goff S, Ketterer G, Wessler I, Racke K: Inhibition of arginase in rat and rabbit alveolar macrophages by N omega-hydroxy-D, L-indospicine, effects on L-arginine utilization by nitric oxide synthase. Br J Pharmacol 1997, 121:395-400.
11. Mori M, Gotoh T: Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 2000, 275:715-719.
12. Mori M, Gotoh T: Arginine metabolic enzymes, nitric oxide and infection. J Nutr 2004, 134(Suppl 10):2820S-2825S.
13. Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, Ratjen F: Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study. Eur Respir J 2005, 25:62-68.
14. Liappis N, Gobien N, Schlebusch H: Reference values of fasting serum levels of free amino acids in children. Klin Padiatr 1990, 202:161-167.
15. Closs EI, Simon A, Vekony N, Rotmann A: Plasma membrane transporters for arginine. J Nutr 2004, 134(Suppl 10):2752S-2759S.
16. Bussiere FI, Chaturvedi R, Cheng Y, Gobert AP, Asim M, Blumberg DR, Xu H, Kim PY, Hacker A, Casero RA Jr, Wilson KT: Spermine causes loss of innate immune response to Helicobacter pylori by inhibition of inducible nitric-oxide synthase translation. J Biol Chem 2005, 280:2409-2412.
17. Ho LP, Innes JA, Greening AP: Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998, 12:1290-1294.
18. Grasemann H, Kurtz F, Ratjen F: Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in cystic fibrosis patients. Am J Respir Crit Care Med in press. 2006 Apr 20
19. Gaston B, Singel D, Doctor A, Stamler JS: S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 2006, 173:1186-1193.
20. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, McMahon T, Stamler JS: Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998, 351:1317-1319.
21. Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, Stamler JS: Protection from experimental asthma by an endogenous bronchodilator. Science 2005, 308:1618-1621.
22. Fang K, Johns R, Macdonald T, Kinter M, Gaston B: S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol 2000, 279:L716-L721.
23. Chen L, Patel RP, Teng X, Bosworth CA, Lancaster JR Jr, Matalon S: Mechanisms of cystic fibrosis transmembrane conductance regulator activation by s-nitrosoglutathione. J Biol Chem 2006, 281:9190-9199.
24. Howard M, Fischer H, Roux J, Santos BC, Gullans SR, Yancey PH, Welch WJ: Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function. J Biol Chem 2003, 278:35159-35167.
25. Andersson C, Gaston B, Roomans GM: S-Nitrosoglutathione induces functional DeltaF508-CFTR in airway epithelial cells. Biochem Biophys Res Commun 2002, 297:552-557.
26. Lyons J, Rauh-Pfeiffer A, Yu YM, Lu XM, Zurakowski D, Tompkins RG, Ajami AM, Young VR, Castillo L: Blood glutathione synthesis rates in healthy adults receiving a sulfur amino acid-free diet. Proc Natl Acad Sci USA 2000, 97:5071-5076.
27. 2+/ calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998, 273:25804-25808.
28. Stuehr D, Pou S, Rosen GM: Oxygen reduction by nitric-oxide synthases. J Biol Chem 2001, 276:14533-14536.
29. 2+/ calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992, 281:627-630.
30. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL: Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 1996, 93:6770-6774.
31. Stuehr DJ: Enzymes of the L-arginine to nitric oxide pathway. J Nutr 2004, 134(Suppl 10):2748S-2751S.
32. Morrissey BM, Schilling K, Weil JV, Silkoff PE, Rodman DM: Nitric oxide and protein nitration in the cystic fibrosis airway. Arch Biochem Biophys 2002, 406:33-39.
33. Jones KL, Hegab AH, Hillman BC, Simpson KL, Jinkins PA, Grisham MB, Owens MW, Sato E, Robbins RA: Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol 2000, 30:79-85.
34. Balint B, Kharitonov SA, Hanazawa T, Donnelly LE, Shah PL, Hodson ME, Barnes PJ: Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J 2001, 17:1201-1207.
35. King NE, Rothenberg ME, Zimmermann N: Arginine in asthma and lung inflammation. J Nutr 2004, 134(Suppl 10):2830S-2836S.
36. Hoet PH, Nemery B: Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. Am J Physiol Lung Cell Mol Physiol 2000, 278:L417-L433.
37. Mossner J, Hammermann R, Racke K: Concomitant down-regulation of L-arginine transport and nitric oxide (NO) synthesis in rat alveolar macrophages by the polyamine spermine. Pulm Pharmacol Ther 2001, 14:297-305.
38. Baylin SB, Rosenstein BJ, Marton LJ, Lockwood DH: Age-related abnormalities of circulating polyamines and diamine oxidase activity in cystic fibrosis heterozygotes and homozygotes. Pediatr Res 1980, 14:921-925.
39. Morris CR, Poljakovic M, Lavrisha L, Machado L, Kuypers FA, Morris SM Jr: Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med 2004, 170:148-153.
40. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM Jr, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005, 294:81-90.
41. Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, Zaagsma J: Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol 2002, 136:391-398.
42. Maarsingh H, Tio MA, Zaagsma J, Meurs H: Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res 2005, 6:23.
43. Zimmermann N, King NE, Laporte J, Yang M, Mishra A, Pope SM, Muntel EE, Witte DP, Pegg AA, Foster PS, Hamid Q, Rothenberg ME: Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest 2003, 111:1863-1874.